LRRK2 and Parkinson disease: Mutations in LRRK2 (PARK8, dardarin) were first identified in autosomal dominant, mostly late-onset families with Parkinson’s disease (Funayama et al., 2002; Paisán-Ruíz et al., 2004; Zimprich et al., 2004).